{"AllianceGenome": "1133", "HGNC": "1133", "MIM": "300300", "_id": "695", "_version": 1, "accession": {"genomic": ["AF375615.1", "AH003036.2", "AH003105.2", "AH005364.2", "AH006678.3", "AL035422.12", "CH471115.1", "CP068255.2", "DQ124931.1", "KT584923.1", "MN687943.1", "NC_000023.11", "NC_060947.1", "NG_009616.1", "OM283292.1", "S69983.1", "U78027.1"], "protein": ["AAA61479.1", "AAB60639.1", "AAB64205.1", "AAF37332.1", "AAF37333.1", "AAF37334.1", "AAF37335.1", "AAF37336.1", "AAF37337.1", "AAF37338.1", "AAF37339.1", "AAF37340.1", "AAF37341.1", "AAF61477.1", "AAI09080.1", "AAI09081.1", "AAZ38824.1", "AGW32074.1", "BAG37008.1", "BAG51864.1", "CAA41728.1", "CAI59836.1", "CAI59837.1", "CAI59838.1", "CAI59839.1", "CAI59840.1", "CAI59842.1", "CAJ19681.1", "CAJ19682.1", "CAJ19683.1", "CAJ19684.1", "CAJ19685.1", "CAJ19686.1", "CAJ19687.1", "CAJ19688.1", "CAJ19689.1", "CAJ19690.1", "CAJ19691.1", "CAJ19692.1", "EAX02856.1", "EAX02857.1", "EAX02858.1", "NP_000052.1", "NP_001274273.1", "NP_001274274.1", "Q06187.3", "UKZ26898.1"], "rna": ["AF153364.1", "AF153755.1", "AF153756.1", "AF153757.1", "AF153758.1", "AF153759.1", "AF153760.1", "AF153761.1", "AF153762.1", "AF153763.1", "AF153764.1", "AJ888376.1", "AJ888377.1", "AJ888378.1", "AJ888379.1", "AJ888380.1", "AJ888381.1", "AK057105.1", "AK225577.1", "AK309851.1", "AK314382.1", "AM051275.1", "AM051276.1", "AM051277.1", "AM051278.1", "AM051279.1", "AM051280.1", "AM051281.1", "AM051282.1", "AM051283.1", "AM051284.1", "AM051285.1", "AM051286.1", "AU107296.1", "AV733045.1", "BC109079.1", "BC109080.1", "DA619542.1", "DB331677.1", "DB636737.1", "KF241986.1", "NM_000061.3", "NM_001287344.2", "NM_001287345.2", "X58957.1"], "translation": [{"protein": "NP_000052.1", "rna": "NM_000061.3"}, {"protein": "BAG37008.1", "rna": "AK314382.1"}, {"protein": "CAJ19687.1", "rna": "AM051281.1"}, {"protein": "CAI59840.1", "rna": "AJ888381.1"}, {"protein": "AAI09080.1", "rna": "BC109079.1"}, {"protein": "CAI59837.1", "rna": "AJ888378.1"}, {"protein": "CAA41728.1", "rna": "X58957.1"}, {"protein": "BAG51864.1", "rna": "AK057105.1"}, {"protein": "CAI59836.1", "rna": "AJ888377.1"}, {"protein": "AAF37339.1", "rna": "AF153762.1"}, {"protein": "CAJ19684.1", "rna": "AM051278.1"}, {"protein": "AAF37337.1", "rna": "AF153760.1"}, {"protein": "AAI09081.1", "rna": "BC109080.1"}, {"protein": "CAJ19690.1", "rna": "AM051284.1"}, {"protein": "AAF37341.1", "rna": "AF153764.1"}, {"protein": "CAI59839.1", "rna": "AJ888380.1"}, {"protein": "AAF37333.1", "rna": "AF153756.1"}, {"protein": "AAF37338.1", "rna": "AF153761.1"}, {"protein": "AAF61477.1", "rna": "AF153364.1"}, {"protein": "CAJ19689.1", "rna": "AM051283.1"}, {"protein": "CAJ19691.1", "rna": "AM051285.1"}, {"protein": "AAF37334.1", "rna": "AF153757.1"}, {"protein": "CAJ19692.1", "rna": "AM051286.1"}, {"protein": "CAJ19685.1", "rna": "AM051279.1"}, {"protein": "AGW32074.1", "rna": "KF241986.1"}, {"protein": "CAJ19688.1", "rna": "AM051282.1"}, {"protein": "CAJ19682.1", "rna": "AM051276.1"}, {"protein": "AAF37335.1", "rna": "AF153758.1"}, {"protein": "NP_001274274.1", "rna": "NM_001287345.2"}, {"protein": "CAJ19683.1", "rna": "AM051277.1"}, {"protein": "CAI59838.1", "rna": "AJ888379.1"}, {"protein": "AAF37336.1", "rna": "AF153759.1"}, {"protein": "CAJ19681.1", "rna": "AM051275.1"}, {"protein": "NP_001274273.1", "rna": "NM_001287344.2"}, {"protein": "CAI59842.1", "rna": "AJ888376.1"}, {"protein": "CAJ19686.1", "rna": "AM051280.1"}, {"protein": "AAF37340.1", "rna": "AF153763.1"}, {"protein": "AAF37332.1", "rna": "AF153755.1"}]}, "alias": ["AGMX1", "AT", "ATK", "BPK", "IGHD3", "IMD1", "PSCTK1", "XLA"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": [{"classification": "definitive", "classification_date": "2020-10-20T16:00:00.000Z", "disease_label": "Bruton-type agammaglobulinemia", "gcep": "Antibody Deficiencies Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0010421", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_8dc4d594-2103-46ad-a786-f4bda9b95995-2020-10-20T160000.000Z", "sop": "SOP7"}, {"classification": "disputed", "classification_date": "2020-11-17T17:00:00.000Z", "disease_label": "isolated growth hormone deficiency type III", "gcep": "Antibody Deficiencies Gene Curation Expert Panel", "moi": "XL", "mondo": "MONDO:0010615", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_6341781b-9ba9-41b1-889a-8d65a9b3ebb7-2020-11-17T170000.000Z", "sop": "SOP7"}]}, "ec": "2.7.10.2", "ensembl": {"gene": "ENSG00000010671", "protein": ["ENSP00000308176", "ENSP00000483570", "ENSP00000512053", "ENSP00000512054", "ENSP00000512055", "ENSP00000512056", "ENSP00000512057", "ENSP00000512058", "ENSP00000512059", "ENSP00000512060", "ENSP00000512061", "ENSP00000512062", "ENSP00000512063", "ENSP00000512064", "ENSP00000512065", "ENSP00000512066", "ENSP00000512067", "ENSP00000512068", "ENSP00000512069", "ENSP00000512070", "ENSP00000512071", "ENSP00000512078"], "transcript": ["ENST00000308731", "ENST00000464006", "ENST00000464567", "ENST00000470069", "ENST00000470329", "ENST00000478995", "ENST00000488970", "ENST00000621635", "ENST00000695614", "ENST00000695615", "ENST00000695616", "ENST00000695617", "ENST00000695618", "ENST00000695619", "ENST00000695620", "ENST00000695621", "ENST00000695622", "ENST00000695623", "ENST00000695624", "ENST00000695625", "ENST00000695626", "ENST00000695627", "ENST00000695628", "ENST00000695629", "ENST00000695630", "ENST00000695631", "ENST00000695632", "ENST00000695633", "ENST00000695634", "ENST00000695643", "ENST00000703407"], "translation": [{"protein": "ENSP00000512053", "rna": "ENST00000695614"}, {"protein": "ENSP00000512054", "rna": "ENST00000695615"}, {"protein": "ENSP00000512055", "rna": "ENST00000695616"}, {"protein": "ENSP00000512056", "rna": "ENST00000695617"}, {"protein": "ENSP00000512057", "rna": "ENST00000703407"}, {"protein": "ENSP00000483570", "rna": "ENST00000621635"}, {"protein": "ENSP00000512058", "rna": "ENST00000695618"}, {"protein": "ENSP00000512059", "rna": "ENST00000695619"}, {"protein": "ENSP00000308176", "rna": "ENST00000308731"}, {"protein": "ENSP00000512060", "rna": "ENST00000695620"}, {"protein": "ENSP00000512061", "rna": "ENST00000695621"}, {"protein": "ENSP00000512062", "rna": "ENST00000695622"}, {"protein": "ENSP00000512063", "rna": "ENST00000695623"}, {"protein": "ENSP00000512064", "rna": "ENST00000695625"}, {"protein": "ENSP00000512065", "rna": "ENST00000695626"}, {"protein": "ENSP00000512066", "rna": "ENST00000695627"}, {"protein": "ENSP00000512067", "rna": "ENST00000695628"}, {"protein": "ENSP00000512068", "rna": "ENST00000695629"}, {"protein": "ENSP00000512069", "rna": "ENST00000695630"}, {"protein": "ENSP00000512070", "rna": "ENST00000695631"}, {"protein": "ENSP00000512071", "rna": "ENST00000470329"}, {"protein": "ENSP00000512078", "rna": "ENST00000695643"}], "type_of_gene": "protein_coding"}, "entrezgene": "695", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.9557852, "exp_mis": 149.5318251, "exp_syn": 60.477972, "lof_z": 4.64156275938298, "mis_z": 4.38116808990503, "mu_lof": 1.95826486056e-06, "mu_mis": 1.83205755482e-05, "mu_syn": 6.89894210747e-06, "n_lof": 0.0, "n_mis": 40.0, "n_syn": 56.0, "p_li": 0.999563220319725, "p_null": 1.40582466063449e-09, "p_rec": 0.000436778274450126, "syn_z": 0.356970258041911}, "bp": 1980, "cds_end": 100630272, "cds_start": 100604872, "n_exons": 18, "nonpsych": {"exp_lof": 19.6361143, "exp_mis": 135.3529248, "exp_syn": 54.577352, "lof_z": 4.35190793999983, "mis_z": 4.17727124583159, "mu_lof": 1.95826486056e-06, "mu_mis": 1.83205755482e-05, "mu_syn": 6.89894210747e-06, "n_lof": 0.0, "n_mis": 39.0, "n_syn": 50.0, "p_li": 0.999092373961948, "p_null": 1.01887045112928e-08, "p_rec": 0.00090761584934716, "syn_z": 0.39009593232068}, "nontcga": {"exp_lof": 19.9030866, "exp_mis": 136.0976983, "exp_syn": 54.98859863, "lof_z": 4.40090002497121, "mis_z": 4.23202280540427, "mu_lof": 1.95826486056e-06, "mu_mis": 1.83205755482e-05, "mu_syn": 6.89894210747e-06, "n_lof": 0.0, "n_mis": 37.0, "n_syn": 50.0, "p_li": 0.999096821191294, "p_null": 8.23902096293827e-09, "p_rec": 0.000903170569685407, "syn_z": 0.42595591334776}, "transcript": "ENST00000308731.7"}, "exons": [{"cdsend": 101375284, "cdsstart": 101349884, "chr": "X", "position": [[101349450, 101349956], [101353193, 101353351], [101353869, 101353988], [101354629, 101354694], [101356051, 101356268], [101356783, 101356955], [101357508, 101357583], [101358309, 101358437], [101358616, 101358696], [101359292, 101359347], [101360087, 101360150], [101360567, 101360755], [101362172, 101362240], [101362560, 101362689], [101369997, 101370079], [101371632, 101371701], [101374535, 101374634], [101375143, 101375314], [101386061, 101386191]], "strand": -1, "transcript": "NM_000061", "txend": 101386191, "txstart": 101349450}, {"cdsend": 101390549, "cdsstart": 101349884, "chr": "X", "position": [[101349446, 101349956], [101353193, 101353351], [101353869, 101353988], [101354629, 101354694], [101356051, 101356268], [101356783, 101356955], [101357508, 101357583], [101358309, 101358437], [101358616, 101358696], [101359292, 101359347], [101360087, 101360150], [101360567, 101360755], [101362172, 101362240], [101362560, 101362689], [101369997, 101370079], [101371632, 101371701], [101374535, 101374634], [101375143, 101375314], [101390477, 101390796]], "strand": -1, "transcript": "NM_001287344", "txend": 101390796, "txstart": 101349446}, {"cdsend": 101375284, "cdsstart": 101349884, "chr": "X", "position": [[101349446, 101349956], [101353193, 101353351], [101353869, 101353988], [101354629, 101354694], [101358373, 101358437], [101358616, 101358696], [101359292, 101359347], [101360087, 101360150], [101360567, 101360755], [101362172, 101362240], [101362560, 101362689], [101369997, 101370079], [101371632, 101371701], [101374535, 101374634], [101375143, 101375314], [101377858, 101378023], [101386061, 101386224]], "strand": -1, "transcript": "NM_001287345", "txend": 101386224, "txstart": 101349446}], "exons_hg19": [{"cdsend": 100630272, "cdsstart": 100604872, "chr": "X", "position": [[100604437, 100604944], [100608181, 100608339], [100608857, 100608976], [100609617, 100609682], [100611039, 100611256], [100611771, 100611943], [100612496, 100612571], [100613297, 100613425], [100613604, 100613684], [100614280, 100614335], [100615075, 100615138], [100615555, 100615743], [100617160, 100617228], [100617548, 100617677], [100624985, 100625067], [100626620, 100626689], [100629523, 100629622], [100630131, 100630302], [100641049, 100641179]], "strand": -1, "transcript": "NM_000061", "txend": 100641179, "txstart": 100604437}, {"cdsend": 100645537, "cdsstart": 100604872, "chr": "X", "position": [[100604434, 100604944], [100608181, 100608339], [100608857, 100608976], [100609617, 100609682], [100611039, 100611256], [100611771, 100611943], [100612496, 100612571], [100613297, 100613425], [100613604, 100613684], [100614280, 100614335], [100615075, 100615138], [100615555, 100615743], [100617160, 100617228], [100617548, 100617677], [100624985, 100625067], [100626620, 100626689], [100629523, 100629622], [100630131, 100630302], [100645465, 100645784]], "strand": -1, "transcript": "NM_001287344", "txend": 100645784, "txstart": 100604434}, {"cdsend": 100630272, "cdsstart": 100604872, "chr": "X", "position": [[100604434, 100604944], [100608181, 100608339], [100608857, 100608976], [100609617, 100609682], [100613361, 100613425], [100613604, 100613684], [100614280, 100614335], [100615075, 100615138], [100615555, 100615743], [100617160, 100617228], [100617548, 100617677], [100624985, 100625067], [100626620, 100626689], [100629523, 100629622], [100630131, 100630302], [100632846, 100633011], [100641049, 100641212]], "strand": -1, "transcript": "NM_001287345", "txend": 100641212, "txstart": 100604434}], "generif": [{"pubmed": 11434777, "text": "Authors showed that human Btk kinase-/SH2 domain mutants, expressed in Btk-deficient DT40 cell line, inhibit Hydrogen Peroxide-induced Tyrosine phosphorylation of PLCG2; this phosphorylation is restored by intact/wild-type (human) Btk. PH domain mutant"}, {"pubmed": 11434777, "text": "Btk deficiency results in significantly impaired hydrogen peroxide-induced calcium signaling and reduced tyrosine phosphorylation of phospholipase Cgamma2 in cultured cells."}, {"pubmed": 11434777, "text": "In hydrogen peroxide-stimulated DT40 cells, BLNK is phosphorylated by Syk and not by Btk."}, {"pubmed": 11438999, "text": "mutational analysis in Spanish X linked agammaglobulinemia patients"}, {"pubmed": 11665629, "text": "Direct stimulation of Bruton's tyrosine kinase by G protein alpha subunits"}, {"pubmed": 11668622, "text": "mutations in Turkish patients with presumed X-linked agammaglobulinemia"}, {"pubmed": 11742120, "text": "changes in the local concentration of Btk itself, or co-localization with exogenous signaling molecules that have high affinity for either proline sequence or the SH3 domain, can significantly alter species composition and regulate Btk kinase activity"}, {"pubmed": 11788586, "text": "Interaction of Bruton's tyrosine kinase and protein kinase Ctheta in platelets"}, {"pubmed": 11877742, "text": "Interaction between Btk TH and SH3 domain"}, {"pubmed": 11920564, "text": "A total of 391 genes were found to be differentially expressed in BTK(-)cells, including kinases and transcriptions factors. Furthermore, one expressed sequence tag and eight complementary DNA clones with unknown function were down-regulated."}, {"pubmed": 12001708, "text": "Review article on X-linked agammaglobulinemia. The BTK gene is the primary defect in this disease."}, {"pubmed": 12204007, "text": "Flow cytometry revealed deficient expression of BTK protein in 10 of the 13 families, and this is the first report of the diagnosis of XLA by analysis of mutations of the BTK gene in Brazilian patients."}, {"pubmed": 12405164, "text": "the presence of wild-type BTK transcripts can be one of the many factors that influence the clinical and immunological phenotype in X-linked agammaglobulinemia."}, {"pubmed": 12437073, "text": "CD40 is a surface receptor through which the activity of Btk can be stimulated in human B cells."}, {"pubmed": 12724322, "text": "Btk is a Toll/interleukin-1 receptor domain-binding protein that is important for NFkappaB activation by TLR4"}, {"pubmed": 12768435, "text": "Mutations were identified in BTK including a novel sequence deletion."}, {"pubmed": 12810683, "text": "Data show that overexpression of Bruton's tyrosine kinase results in the stabilization of tumor necrosis factor alpha mRNA via the 3' untranslated region."}, {"pubmed": 12854903, "text": "Defective expression of Bruton's tyrosine kinase in acute lymphoblastic leukemia in infants."}, {"pubmed": 12970174, "text": "results indicate that, contrary to Src and Abl, Btk might not require an assembled conformation for the regulation of its activity"}, {"pubmed": 14634110, "text": "Conclusion of Btk transgene study is that autophosphorylation at residue Y223 is not essential for Btk function in vivo except for regulation of lambda light chain usage; and Btk partially acts as an adapter molecule independent of its catalytic activity."}, {"pubmed": 14974089, "text": "Twenty-two novel mutations including one large deletion comprising the coding sequence from exon 11 to 18 in European X-linked agammaglobulinemia patients."}, {"pubmed": 15082835, "text": "Conservation and covariance in mutations of BTK domain sequences causing agammaglobulinemia were studied."}, {"pubmed": 15466623, "text": "Btk is essential in regulating thresholds for human B cell tolerance."}, {"pubmed": 15712380, "text": "2 insertions, an SVA element and an AluY sequence, occurred 12 bp before the end of exon 9. Both had the typical hallmarks of a retrotransposon insertion including target site duplication and a long poly A tail."}, {"pubmed": 15849198, "text": "required for the signaling pathway activated by TLR4, which culminates in phosphorylation of p65 on serine 536 promoting transactivation by NFkappaB"}, {"pubmed": 15894173, "text": "Ca2+-independent activation of Bruton's tyrosine kinase is required for store-mediated Ca2+ entry in human platelets"}, {"pubmed": 16141323, "text": "lack of BTK expression or expression of dominant-negative splice variants in B cell precursor leukemia cells can (i) inhibit differentiation beyond the pre-B cell stage and (ii) protect from radiation-induced apoptosis"}, {"pubmed": 16159644, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 16300960, "text": "Review summarizes how activated Btk transmits survival signals that are essential for the transforming activity of oncogenic Abl tyrosine kinase."}, {"pubmed": 16439361, "text": "Mal phosphorylation has an effect on tyrosine during signaling by TLR2 and TLR4 and Btk is the kinase involved"}, {"pubmed": 16517732, "text": "data provide evidence for a common requirement for Btk in toll-like receptor 2 (TLR2)- and TLR4-mediated induction of two important proinflammatory cytokines, TNF and IL-1beta"}, {"pubmed": 16751014, "text": "Btk is not essential for early lipopolysaccharide signaling in human monocytes."}, {"pubmed": 16951917, "text": "splice mutations of the BTK gene may have roles in X-linked agammaglobulinemia"}, {"pubmed": 17264076, "text": "analysis of BTK activation mechanism and steady state kinetics"}, {"pubmed": 17707910, "text": "A first report of an X-linked Agammaglobulinemia patient with a polymorphism in Btk SH3 domain has been identified after sequencing of the entire gene."}, {"pubmed": 17765309, "text": "Most of mutations were located at the kinase domain of Btk and, less frequently, they were found in PH and SH2 domains. Protein expression was also affected since most of the patients did not express or express very low Btk."}, {"pubmed": 17932028, "text": "Btk as a key signaling molecule that interacts with and acts downstream of TLR8 and TLR9."}, {"pubmed": 18022864, "text": "Plasmacytoid dendritic cells express a signalosome consisting of Lyn, Syk, Btk, Slp65 (Blnk) and PLCgamma2."}, {"pubmed": 18051214, "text": "Of 9 CVID patients from a single Taiwanese tertiary care hospital, we identified 2 cousins with decreased Btk expression who had a mutated (Asp521Val) kinase domain of Btk (1694A>T in exon 15)"}, {"pubmed": 18241233, "text": "results suggest that none of the X-linked agammaglobulinaemia-associated Btk mutants with significant protein expression have a dominant negative effect over wild type Btk function"}, {"pubmed": 18548107, "text": "Bruton's tyrosine kinase is not essential for Bcr-Abl-mediated transformation of lymphoid or myeloid cells."}, {"pubmed": 18726917, "text": "Btk mutation is associated with myelodysplastic syndrome in X-linked agammaglobulinemia."}, {"pubmed": 18776760, "text": "Mutations were categorized as mild or severe and patients were evaluated for the clinical severity of disease"}, {"pubmed": 18776760, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18809383, "text": "The crystal structure of the Btk PH domain in complex with dibutylyl-phosphatidylinositol-3,4,5-triphosphate was determined."}, {"pubmed": 19017959, "text": "Btk-regulated eicosanoid and ROS production occurs downstream of PI3K."}, {"pubmed": 19039656, "text": "mutations in the gene associated with X-linked agammaglobulinemia in mainland China"}, {"pubmed": 19206206, "text": "Study provides important mechanistic insights into Btk kinase activity and phosphorylation-mediated regulation."}, {"pubmed": 19212330, "text": "in a B-cell lymphoma cell line, physical interaction was observed between BTK and BAG3, possibly upon modifications induced by stress"}, {"pubmed": 19342689, "text": "miR-346 indirectly regulated IL-18 release by indirectly inhibiting LPS-induced Bruton's tyrosine kinase expression in LPS-activated rheumatoid arthritis fibroblast-like synoviocytes"}, {"pubmed": 19464057, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19471023, "text": "we show that BTK increased the abundance of CDC73 in the absence of stimulation and that CDC73 acted as a repressor of beta-catenin-mediated transcription in human colorectal cancer cells and B cells"}, {"pubmed": 19859091, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19904586, "text": "genotype-phenotype correlation in Chinease patients with X-linked agammaglobulinemia"}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19949111, "text": "our results indicate a novel regulatory mechanism for Btk transcription and reveal a previously unrecognized posttranslational modification of the Btk protein and its association with phosphorylation in B cell activation."}, {"pubmed": 20052711, "text": "the crystal structures of the human BTK kinase domain bound to either Dasatinib (BMS-354825) at 1.9 A resolution or to 4-amino-5-(4-phenoxyphenyl)-7H-pyrrolospyrimidin- 7-yl-cyclopentane at 1.6 A resolution were reported."}, {"pubmed": 20056178, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20574453, "text": "transduction of human BTK corrects B-cell development and antigen-specific antibody responses in Btk-/- mice, thus indicating the feasibility of lentiviral gene therapy for XLA, provided that BTK expression does not vastly exceed normal levels"}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20634142, "text": "Loss of Btk in X-linked agammaglobulinemia neutrophils does not impair functional responses to toll-like receptors[ signals."}, {"pubmed": 20715177, "text": "This study provides novel evidence that Btk signaling is crucial for optimal actin cytoskeletal organization and lacunar resorption in isolated osteoclasts."}, {"pubmed": 21039741, "text": "Data show that sixteen different mutations of BTK gene were identified in 18 congenital agammaglobulinemia patients."}, {"pubmed": 21422473, "text": "Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765."}, {"pubmed": 21482705, "text": "A novel pathway of Btk regulation via protein kinase C phosphorylation of IBtkgamma."}, {"pubmed": 21622861, "text": "Activation of Btk promotes B cell spreading, B cell receptor microcluster formation, and actin polymerization and accumulation."}, {"pubmed": 21659545, "text": "our data identify Btk as a positive regulator in the ITAM-mediated TREM-1/DAP12 pathway and suggest its implication in inflammatory processes."}, {"pubmed": 21784852, "text": "a novel role for Btk in HGF-induced DC inhibition."}, {"pubmed": 21991724, "text": "X-linked agammaglobulinemia is caused by mutations in the gene encoding Bruton tyrosine kinase."}, {"pubmed": 22053596, "text": "We screened 52 members of 4 unrelated Taiwanese families with the BTK gene defect for BTK gene mutation and found that there were 6 symptomatic living patients with a confirmed defect."}, {"pubmed": 22312945, "text": "Absence of Btk expression in patient 4 confirmed"}, {"pubmed": 22366891, "text": "Our data identify Btk as a critical gatekeeper of neutrophil responses"}, {"pubmed": 22378381, "text": "The L111P and E650G variations are not located directly in protein-protein interfaces but close to them. They distorted the native structural conformation of the BTK protein."}, {"pubmed": 22527282, "text": "mapped the interaction site to the C terminus of the Btk SH3 domain"}, {"pubmed": 22589540, "text": "Data suggest a role of tyrosine kinase Btk in the regulation of immune cell unctions and innate inflammatory response."}, {"pubmed": 22689860, "text": "Results indicate Bruton tyrosine kinase (Btk) activation mediating osteolysis and growth of multiple myeloma (MM) cells, supporting PCI-32765 as a therapeutic in MM."}, {"pubmed": 23239500, "text": "study reveals the existence of Btk-dependent molecular cooperation between FcgammaRIIa and TLR4 signaling cascades in LPS-\"primed\" human neutrophils"}, {"pubmed": 23581641, "text": "These results suggest that the function of BTK warrants further investigation, and BTK expression might be used as a prognostic indicator for patients with MM."}, {"pubmed": 23754751, "text": "The activated serine/threonine kinase Akt/protein kinase B phosphorylated BTK on two sites prior to 14-3-3 zeta binding."}, {"pubmed": 23913792, "text": "Studied loss-of-function of human tyrosine kinases to i.d. survival factors for breast cancer cells; found downregulation or inhibition of Bruton's tyrosine kinase causes apoptosis; overexpression inhibits apoptosis induced by Dox in breast cancer cells."}, {"pubmed": 23967355, "text": "new insights into the role of BTK, an important target for autoimmune diseases, in B cell activation"}, {"pubmed": 23977012, "text": "BTK-induced activating phosphorylation is critical for the optimal transcription factor function of Ikaros."}, {"pubmed": 24307721, "text": "Here we describe that BTK is constitutively phosphorylated in the majority of acute myeloid leukemia samples tested, with BTK phosphorylation correlating highly with the cell's cytotoxic sensitivity toward ibrutinib."}, {"pubmed": 24307874, "text": "five structures, K12R, K19E, R28C/H, and E41K mutants, were classified as \"functional mutations,\" whereas L11P, S14F, F25S, and Y40N were grouped into \"folding mutations\""}, {"pubmed": 24311722, "text": "BTK is a critical kinase for chronic lymphocytic leukemia development and expansion and thus an important target of ibrutinib."}, {"pubmed": 24375473, "text": "Data indicate Bruton's tyrosine kinase (Btk) as a key molecule in TLR9 signaling in plasmacytoid dendritic cells (PDCs) and the TLR7 and TLR9 pathways can be dissociated in PDCs."}, {"pubmed": 24383975, "text": "a novel base substitution in the first nucleotide of intron 9 in the BTK gene is described"}, {"pubmed": 24510558, "text": "The mothers of 5 patients were also detected with BTK gene mutations."}, {"pubmed": 24612681, "text": "Bruton tyrosine kinase mediates TLR9-dependent human dendritic cell activation."}, {"pubmed": 24658273, "text": "BTK is a key enzyme in various signalling pathways in B cell malignancies and in the the context of drug therapies. [Review]"}, {"pubmed": 24712864, "text": "Data indicate RN486 as potent and selective Bruton's tyrosine kinase (BTK) inhibitor and potential treatments for Rheumatoid arthritis."}, {"pubmed": 24722985, "text": "We observed that Nef interacts with the Tec family members Bmx, Btk, and Itk but not Tec or Txk."}, {"pubmed": 24840642, "text": "Docking and physicochemical studies indicated that BTK was involved in close contact with Tyr86 and Tyr106 of MAL, whereas PKCdelta may phosphorylate Tyr106 only."}, {"pubmed": 24869598, "text": "Resistance to the irreversible BTK inhibitor ibrutinib often involves mutation of a cysteine residue where ibrutinib binding occurs.We identified a cysteine-to-serine mutation in BTK at the binding site of ibrutinib in five patients."}, {"pubmed": 24970801, "text": "Data indicate that dual inhibition of Brutons tyrosine kinase (BTK) and mTOR serine-threonine kinases as a potential treatment for ABC-subtype diffuse large B cell lymphoma."}, {"pubmed": 25083818, "text": "BTK is involved in determining proliferative, quiescent or metastatic phenotypes of myeloma cells."}, {"pubmed": 25170122, "text": "Unfolded protein response activation following surface immunoglobulin M stimulation in vitro is dependent on the activity of BTK and SYK."}, {"pubmed": 25189416, "text": "Cysteine 481 to serine BTK mutation confers ibrutinib resistance of chronic lymphocytic leukemia cells."}, {"pubmed": 25284608, "text": "Combination of ibrutinib with ABT-199: synergistic effects on proliferation inhibition and apoptosis in mantle cell lymphoma cells through perturbation of BTK, AKT and BCL2 pathways."}, {"pubmed": 25316352, "text": "report of a case in a male with variant form of X-linked agammaglobulinemia (XLA) with partial B cell function that results from a missense mutation (c.1117C > G) in exon 13 of the BTK gene; four female carriers were found in the family"}, {"pubmed": 25413232, "text": "The immunoglobulin tail tyrosine motif in the cytoplasmic segments of membrane-bound IgGs acts as the principle signal amplifier by incorporating a Grb2-Btk signaling."}, {"pubmed": 25433814, "text": "we report the pattern of expression of Btk in a large collection of different types of lymphoma."}, {"pubmed": 25486872, "text": "miR-155 affects chemoimmunotherapy outcome and is modulated by Bruton's tyrosine kinase inhibition with Ibrutinib"}, {"pubmed": 25498455, "text": "Data indicate that ibrutinib-resistant Bruton tyrosine kinase (BTK) mutation is one of the genetic causes of ibrutinib resistance in chronic lymphocytic leukemia (CLL)."}, {"pubmed": 25589346, "text": "BTK is a positive regulator of myeloma stemness"}, {"pubmed": 25589397, "text": "The BTK missense mutation resulted in B cells with reduced BTK and high IgM expression."}, {"pubmed": 25605370, "text": "FLT3-ITD and TLR9 use Bruton tyrosine kinase to activate distinct transcriptional programs mediating AML cell survival and proliferation"}, {"pubmed": 25724205, "text": "Btk not only plays a fundamental role in the regulation of BCR signalling, but may also mediate crosstalk with cytokine signalling pathways through regulation of IL-21-induced phosphorylation of STAT1 in the nuclei of human B cells."}, {"pubmed": 25757060, "text": "X-linked agammaglobulinemia is reported in two siblings with a novel mutation in the BTK gene. They presented with polyarticular juvenile idiopathic arthritis."}, {"pubmed": 25777788, "text": "study investigated all single-nucleotide substitution-caused amino acid variations in the kinase domain of Bruton tyrosine kinase; most disease-causing variations affect conserved and buried residues disturbing protein stability; sixty-seven percent of variations are predicted to be harmful"}, {"pubmed": 25944695, "text": "Data show that Bruton tyrosine kinase (Btk) inhibitor PLS-123 suggested a new direction to pharmacologically modulate Btk function and develop novel therapeutic drug for B-cell lymphoma treatment."}, {"pubmed": 26036311, "text": "We found that chemoresistance was dependent on Btk and JAK2/STAT3, which maintained CSC by inducing Sox-2 and prosurvival genes. We suggest that addition of ibrutinib to cisplatin may improve treatment outcome in ovarian cancer."}, {"pubmed": 26059659, "text": "study indicates that BTK is essential for NLRP3 inflammasome activation and could be a potent therapeutic target in ischaemic stroke"}, {"pubmed": 26089373, "text": "Activates PKC independent of BTK."}, {"pubmed": 26182170, "text": "Letter: report BTK inhibitor ibrutinib induced panniculitis in lymphoid leukemia patients."}, {"pubmed": 26292723, "text": "BTK RNA interference inhibits proliferation of FLT3-ITD acute myeloid leukemia cells."}, {"pubmed": 26383180, "text": "BTK-C is a survival factor in prostate cancer cells."}, {"pubmed": 26387629, "text": "Data indicate that the X linked agammaglobulinemia (XLA) diagnosis was confirmed for six patients with six different mutations."}, {"pubmed": 26475492, "text": "FcgammaRIIB requires Btk and p38 MAPK to mediate antigen-independent inhibition in human B cells."}, {"pubmed": 26540570, "text": "Data show that Bruton tyrosine kinase (BTK)inhibitor Ibrutinib augments MALT lymphoma associated translocation protein (MALT1) inhibition by S-Mepazine in CD79 antigen mutant activated B cell-subtype (ABC) of diffuse large B cell lymphoma (DLBCL)."}, {"pubmed": 26715645, "text": "We report that BTK regulates B-cell and macrophage-mediated T-cell suppression in pancreas adenocarcinomas."}, {"pubmed": 26804170, "text": "BTK, via p65BTK expression, is a novel and powerful oncogene acting downstream of the RAS/MAPK pathway and suggest that its targeting may be a promising therapeutic approach."}, {"pubmed": 26864273, "text": "this review describes contributions of BTK to immune tolerance, including studies testing BTK-inhibitors for treatment of autoimmune diseases"}, {"pubmed": 26880800, "text": "report that BTK is expressed by murine and human MDSCs, and that ibrutinib is able to inhibit BTK phosphorylation in these cells"}, {"pubmed": 26910880, "text": "mutational analysis in cohort of Iranian patients with congenital agammaglobulinemia"}, {"pubmed": 26931785, "text": "Novel BTK mutations have been described in a large cohort of North African patients with X-Linked agammagobulinemia."}, {"pubmed": 26961147, "text": "Strong synergism was observed with pimasertib combined with the PI3K inhibitor idelalisib and the BTK inhibitor ibrutinib in cell lines derived from diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma. The data were confirmed in an in vivo experiment treating DLBCL xenografts with pimasertib and ibrutinib."}, {"pubmed": 27111445, "text": "Inhibition of Btk by inhalation of aerosolized RN983 may be effective as a stand-alone asthma therapy."}, {"pubmed": 27157620, "text": "this study elucidated mechanisms of BCL2 overexpression and association of this survival pathway with the BCR/BTK signaling pathway in MCL, and revealed the role of BTK in noncanonical NF-kappaB activation, which also promotes cancer cell survival."}, {"pubmed": 27287071, "text": "BTK-inhibitor ibrutinib and FK866 resulted in a significant and synergistic anti-Waldenstrom macroglobulinemia cell death, regardless of MYD88 and CXCR4 mutational status."}, {"pubmed": 27630139, "text": "We conclude that despite being involved in oncogenic signals in blood malignancies, BTK has antineoplastic properties in other contexts, such as the enhancement of p53's tumor suppressor responses"}, {"pubmed": 27792904, "text": "LMP2A signaling results in STAT3 phosphorylation in B cells through a PI3K/BTK-dependent pathway."}, {"pubmed": 28216434, "text": "these data show that BTK is a critical NLRP3 inflammasome regulator"}, {"pubmed": 28273548, "text": "Bone marrow mesenchymal stem cells could increase myeloma stemness via activation of the BTK signal pathway."}, {"pubmed": 28369144, "text": "the results show that the interaction between BTK and ANKRD54 is highly selective, since it was also identified in a screen using human SH3-domainome. A novel finding is that BTK not only binds to ANKRD54, but stands out as the preferred interactor, being highly dominant over all other human SH3-domains."}, {"pubmed": 28398200, "text": "Case Report: Btk mutation responsible for X-Linked agammaglobulinemia manifesting as Pseudomonas aeruginosa liver abscess."}, {"pubmed": 28422989, "text": "The lack of BTK does not impair monocytes and polymorphonuclear cells functions in X-linked agammaglobulinemia under treatment with intravenous immunoglobulin."}, {"pubmed": 28428442, "text": "Ibrutinib-resistant TMD8 cells had higher BCL2 gene expression and increased sensitivity to ABT-199, a BCL-2 inhibitor. Consistently, clinical samples from ABC-DLBCL patients who experienced poorer response to ibrutinib had higher BCL2 gene expression. We further demonstrated synergistic growth suppression by ibrutinib and ABT-199 in multiple ABC-DLBCL, GCB-DLBCL, and follicular lymphoma cell lines."}, {"pubmed": 28548645, "text": "BTK-mediated signaling was found to be highly attenuated accompanied by a shift in PI3K/AKT and apoptosis regulation-associated genes/proteins. Cytotoxicity studies using the AKT inhibitor, MK2206+/-ibrutinib, and the Bcl-2-specific inhibitor, venetoclax+/-ibrutinib, demonstrated synergistic loss of cell viability"}, {"pubmed": 28573668, "text": "Resistant BTK mutants reconstituted B cell receptor-triggered chemokine secretion in the presence of corresponding inhibitors, demonstrating that BTK activity is connected with cell-intrinsic functions of malignant B cells with importance for their dialogue with the micro-environment."}, {"pubmed": 28879546, "text": "The Btk-dependent PIP5K1gamma lipid kinase activation by Fas counteracts FasL-induced cell death."}, {"pubmed": 28946903, "text": "Study shows that high BTK expression predicts poor outcome in patients with glioma. Its overexpression is required for EGFR-induced NF-kappaB activation."}, {"pubmed": 29381098, "text": "While BTK/PLCG2 mutations have characteristics suggesting that they can drive ibrutinib resistance, this conclusion remains formally unproven until specific inhibition of such mutations is shown to cause regression of ibrutinib-resistant chronic lymphocytic leukemia . Data suggest that alternative mechanisms of resistance do exist in some patients."}, {"pubmed": 29480835, "text": "Study utilized bone biopsies from patients with metastatic multiple myeloma and demonstrated that tyrosine phosphorylation by Bruton kinase may be a key disease event: Bruton kinase remained translocated to the membrane; upregulation of transcripts of several factors like activins A; increased expression of numerous cytokines that support osteolytic activity."}, {"pubmed": 29496671, "text": "Our findings show that the BTK(Cys481Ser) mutation drives ibrutinib resistance in MYD88-mutated WM and ABC DLBCL cells through reactivation of ERK1/2 and can confer a protective effect on BTK(WT) cells through a paracrine mechanism."}, {"pubmed": 29567473, "text": "Btk acts in the TLR7/8 pathway and mediates Ser-536 phosphorylation of p65 RelA and subsequent nuclear entry in primary human macrophages."}, {"pubmed": 29717662, "text": "REVIEW: Role of Bruton's Tyrosine Kinase in Immune Cell Signaling and Systemic Autoimmunity"}, {"pubmed": 29851337, "text": "Inhibition of BTK with the irreversible inhibitor ibrutinib has emerged as a transformative treatment option for patients with chronic lymphocytic leukemia (CLL), yet >80% of CLL patients develop resistance due to a cysteine to serine mutation at the site covalently bound by ibrutinib (C481S). In cells isolated from CLL patients with the C481S mutation, MT-802 is able to reduce the pool of active, phosphorylated BTK."}, {"pubmed": 30072168, "text": "this study describes clinical and genetic profiles of patients with X-linked agammaglobulinemia from southeast Turkey and novel mutations in BTK gene"}, {"pubmed": 30337526, "text": "The pleiotropic roles of BTK in cancer have been proposed."}, {"pubmed": 30627929, "text": "Allele-Specific BTK Expression in B Cells and Monocytes."}, {"pubmed": 30872780, "text": "Re-expression of SHP1 in GCB DBLCL cells reduces SYK, BLNK, and GSK3 phosphorylation."}, {"pubmed": 30887112, "text": "Bruton's tyrosine kinase associates and phosphorylates IkappaBalpha at Y289 and Y305, promoting NF-kappaB activation."}, {"pubmed": 30940906, "text": "BTK inhibition abrogated CSF1 and IL-10 production in MCL cells."}, {"pubmed": 31019091, "text": "PIP3-mediated dimerization of Btk at the cell membrane is a critical step in Btk activation."}, {"pubmed": 31115091, "text": "A novel Bruton tyrosine kinase gene variation was found in an adult with X-linked agammaglobulinemia during blood cross-matching prior to surgical operation."}, {"pubmed": 31217352, "text": "Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activity."}, {"pubmed": 31534006, "text": "ROR1/CD19 complex effectively substitutes for BCR-BTK signaling to promote activation and growth of mantle cell lymphoma cells"}, {"pubmed": 31591208, "text": "In the resting state, the BTK PH domain binds to the activation loop face of the kinase domain and allosterically alters key sites within the kinase domain."}, {"pubmed": 31801949, "text": "Resistance to BTK inhibition by ibrutinib can be overcome by preventing FOXO3a nuclear export and PI3K/AKT activation in B-cell lymphoid malignancies."}, {"pubmed": 31895698, "text": "Bruton tyrosine kinase deficiency augments NLRP3 inflammasome activation and causes IL-1beta-mediated colitis."}, {"pubmed": 31915195, "text": "Acalabrutinib plus Obinutuzumab in Treatment-Naive and Relapsed/Refractory Chronic Lymphocytic Leukemia."}, {"pubmed": 32184360, "text": "Noncatalytic Bruton's tyrosine kinase activates PLCgamma2 variants mediating ibrutinib resistance in human chronic lymphocytic leukemia cells."}, {"pubmed": 32232486, "text": "Novel BCL2 mutations in venetoclax-resistant, ibrutinib-resistant CLL patients with BTK/PLCG2 mutations."}, {"pubmed": 32473417, "text": "Bruton's tyrosine kinase in systemic lupus erythematosus."}, {"pubmed": 32484802, "text": "Bruton's tyrosine kinase inhibition effectively protects against human IgE-mediated anaphylaxis."}, {"pubmed": 32552675, "text": "Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations."}, {"pubmed": 32640487, "text": "BTK/ITK dual inhibitors: Modulating immunopathology and lymphopenia for COVID-19 therapy."}, {"pubmed": 32705581, "text": "Aberrantly expressed Bruton's tyrosine kinase preferentially drives metastatic and stem cell-like phenotypes in neuroblastoma cells."}, {"pubmed": 33377626, "text": "Novel mutations in hyper-IgM syndrome type 2 and X-linked agammaglobulinemia detected in three patients with primary immunodeficiency disease."}, {"pubmed": 33419778, "text": "Follicular Lymphoma-associated BTK Mutations are Inactivating Resulting in Augmented AKT Activation."}, {"pubmed": 33501616, "text": "X-Linked Agammaglobulinemia Case with TH Domain Missense Mutation in Bruton Tyrosine Kinase."}, {"pubmed": 33526860, "text": "BTK gatekeeper residue variation combined with cysteine 481 substitution causes super-resistance to irreversible inhibitors acalabrutinib, ibrutinib and zanubrutinib."}, {"pubmed": 33735912, "text": "MARCKS affects cell motility and response to BTK inhibitors in CLL."}, {"pubmed": 33760219, "text": "Bruton's agammaglobulinemia tyrosine kinase (Btk) regulates TPAinduced breast cancer cell invasion via PLCgamma2/PKCbeta/NFkappaB/AP1dependent matrix metalloproteinase9 activation."}, {"pubmed": 33876953, "text": "Optimizing Integration and Expression of Transgenic Bruton's Tyrosine Kinase for CRISPR-Cas9-Mediated Gene Editing of X-Linked Agammaglobulinemia."}, {"pubmed": 34181208, "text": "Time-limited, Combined Regimen in Chronic Lymphocytic Leukemia: A Promising Strategy to Achieve a Drug Holiday."}, {"pubmed": 34182127, "text": "Identification of 22 novel BTK gene variants in B cell deficiency with hypogammaglobulinemia."}, {"pubmed": 34729748, "text": "[Genetic study of an X-linked agammaglobulinemia pedigree caused by an BTK mutation]."}, {"pubmed": 34732441, "text": "Clinicopathologic and Prognostic Significance of Bruton's Tyrosine Kinase Expression in Diffuse Large B-Cell Lymphoma."}, {"pubmed": 34799428, "text": "Btk Supports Autoreactive B Cell Development and Protects against Apoptosis but Is Expendable for Antigen Presentation."}, {"pubmed": 35008508, "text": "Spontaneous Platelet Aggregation in Blood Is Mediated by FcgammaRIIA Stimulation of Bruton's Tyrosine Kinase."}, {"pubmed": 35196427, "text": "Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors."}, {"pubmed": 35245483, "text": "Identification of four novel mutations in BTK from six Chinese families with X-linked agammaglobulinemia."}, {"pubmed": 35732327, "text": "Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling."}, {"pubmed": 36226489, "text": "Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy."}, {"pubmed": 36696464, "text": "BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib."}, {"pubmed": 36719376, "text": "Cotargeting of BTK and MALT1 overcomes resistance to BTK inhibitors in mantle cell lymphoma."}, {"pubmed": 37175486, "text": "Differential Regulation of GPVI-Induced Btk and Syk Activation by PKC, PKA and PP2A in Human Platelets."}, {"pubmed": 37407007, "text": "Inhibiting BTK in Chronic Lymphocytic Leukemia."}, {"pubmed": 37638060, "text": "Overexpression of Bruton Tyrosine Kinase Inhibits the Proliferation, Migration, and Invasion of Non-Small Cell Lung Cancer Cells."}, {"pubmed": 37685940, "text": "Influence of Bruton's Tyrosine Kinase (BTK) on Epithelial-Mesenchymal Transition (EMT) Processes and Cancer Stem Cell (CSC) Enrichment in Head and Neck Squamous Cell Carcinoma (HNSCC)."}, {"pubmed": 37706515, "text": "Bruton's Tyrosine Kinase in Ankylosing Spondylitis."}, {"pubmed": 38015751, "text": "Single-Cell RNA-Seq Analysis of Patient Myeloid-Derived Suppressor Cells and the Response to Inhibition of Bruton's Tyrosine Kinase."}, {"pubmed": 38022591, "text": "Expression of Bruton s tyrosine kinase in different type of brain lesions of multiple sclerosis patients and during experimental demyelination."}, {"pubmed": 38137005, "text": "Resisting the Resistance: Navigating BTK Mutations in Chronic Lymphocytic Leukemia (CLL)."}, {"pubmed": 38139452, "text": "Identification of the Axis beta-Catenin-BTK in the Dynamic Adhesion of Chronic Lymphocytic Leukemia Cells to Their Microenvironment."}], "genomic_pos": {"chr": "X", "end": 101390796, "ensemblgene": "ENSG00000010671", "start": 101349338, "strand": -1}, "genomic_pos_hg19": [{"chr": "HG1439_PATCH", "end": 100641183, "start": 100604435, "strand": -1}, {"chr": "X", "end": 100641183, "start": 100604435, "strand": -1}], "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0001780", "qualifier": "involved_in", "term": "neutrophil homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001805", "qualifier": "involved_in", "term": "positive regulation of type III hypersensitivity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0001812", "qualifier": "involved_in", "term": "positive regulation of type I hypersensitivity"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0002250", "qualifier": "involved_in", "term": "adaptive immune response"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0002250", "pubmed": 19290921, "qualifier": "involved_in", "term": "adaptive immune response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002344", "qualifier": "involved_in", "term": "B cell affinity maturation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002553", "qualifier": "involved_in", "term": "histamine secretion by mast cell"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0002639", "qualifier": "involved_in", "term": "positive regulation of immunoglobulin production"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0002721", "pubmed": 19290921, "qualifier": "involved_in", "term": "regulation of B cell cytokine production"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0002755", "qualifier": "involved_in", "term": "MyD88-dependent toll-like receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0002902", "pubmed": 19290921, "qualifier": "involved_in", "term": "regulation of B cell apoptotic process"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006468", "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006468", "pubmed": 11913944, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007498", "pubmed": 8013627, "qualifier": "involved_in", "term": "mesoderm development"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0018108", "pubmed": [11606584, 15509800], "qualifier": "involved_in", "term": "peptidyl-tyrosine phosphorylation"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0018108", "pubmed": 14656219, "qualifier": "involved_in", "term": "peptidyl-tyrosine phosphorylation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0019722", "pubmed": 15046600, "qualifier": "involved_in", "term": "calcium-mediated signaling"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030167", "qualifier": "involved_in", "term": "proteoglycan catabolic process"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030889", "qualifier": "involved_in", "term": "negative regulation of B cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0030890", "qualifier": "involved_in", "term": "positive regulation of B cell proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032496", "qualifier": "involved_in", "term": "response to lipopolysaccharide"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032693", "qualifier": "involved_in", "term": "negative regulation of interleukin-10 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032755", "qualifier": "involved_in", "term": "positive regulation of interleukin-6 production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0032760", "qualifier": "involved_in", "term": "positive regulation of tumor necrosis factor production"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0034614", "qualifier": "involved_in", "term": "cellular response to reactive oxygen species"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035556", "pubmed": [11606584, 15509800], "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IGI", "gocategory": "BP", "id": "GO:0035556", "pubmed": 14656219, "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0035556", "pubmed": 11913944, "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0038095", "qualifier": "involved_in", "term": "Fc-epsilon receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0042113", "pubmed": 19290921, "qualifier": "involved_in", "term": "B cell activation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0045087", "pubmed": 19290921, "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0045579", "pubmed": 19290921, "qualifier": "involved_in", "term": "positive regulation of B cell differentiation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048469", "qualifier": "involved_in", "term": "cell maturation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050766", "qualifier": "involved_in", "term": "positive regulation of phagocytosis"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0050852", "qualifier": "involved_in", "term": "T cell receptor signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0050853", "qualifier": "involved_in", "term": "B cell receptor signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0050853", "pubmed": 15509800, "qualifier": "involved_in", "term": "B cell receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0050853", "pubmed": 19290921, "qualifier": "involved_in", "term": "B cell receptor signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0051092", "pubmed": 19290921, "qualifier": "involved_in", "term": "positive regulation of NF-kappaB transcription factor activity"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0061516", "qualifier": "involved_in", "term": "monocyte proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0071226", "qualifier": "involved_in", "term": "cellular response to molecule of fungal origin"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0097190", "pubmed": 8688094, "qualifier": "involved_in", "term": "apoptotic signaling pathway"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0098761", "qualifier": "involved_in", "term": "cellular response to interleukin-7"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0150153", "qualifier": "involved_in", "term": "positive regulation of interleukin-17A production"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1900227", "pubmed": 34554188, "qualifier": "involved_in", "term": "positive regulation of NLRP3 inflammasome complex assembly"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1901647", "qualifier": "involved_in", "term": "positive regulation of synoviocyte proliferation"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:1990959", "qualifier": "involved_in", "term": "eosinophil homeostasis"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005634", "pubmed": 19290921, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005737", "pubmed": 15046600, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005829", "pubmed": 17823121, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "pubmed": 19290921, "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 17823121, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "pubmed": 19290921, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0031410", "qualifier": "located_in", "term": "cytoplasmic vesicle"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0045121", "pubmed": 15046600, "qualifier": "located_in", "term": "membrane raft"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0048471", "qualifier": "located_in", "term": "perinuclear region of cytoplasm"}], "MF": [{"category": "MF", "evidence": "EXP", "id": "GO:0004713", "pubmed": 7518558, "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004713", "pubmed": 34554188, "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004713", "pubmed": 11913944, "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004715", "qualifier": "enables", "term": "non-membrane spanning protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0004715", "pubmed": 11606584, "qualifier": "enables", "term": "non-membrane spanning protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IGI", "id": "GO:0004715", "pubmed": 14656219, "qualifier": "enables", "term": "non-membrane spanning protein tyrosine kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004715", "pubmed": 19290921, "qualifier": "enables", "term": "non-membrane spanning protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [8892607, 9012831, 9571151, 11788586, 15046600, 15539407, 16969585, 19214191, 22366891, 22939624, 25825872, 25910212], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "TAS", "id": "GO:0005524", "pubmed": 11913944, "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005547", "pubmed": 17823121, "qualifier": "enables", "term": "phosphatidylinositol-3,4,5-trisphosphate binding"}, {"category": "MF", "evidence": "IDA", "id": "GO:0016004", "pubmed": 11606584, "qualifier": "enables", "term": "phospholipase activator activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0042802", "pubmed": 11577348, "qualifier": "enables", "term": "identical protein binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0043274", "pubmed": [11606584, 14656219], "qualifier": "enables", "term": "phospholipase binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0046872", "qualifier": "enables", "term": "metal ion binding"}]}, "homologene": {"genes": [[7955, 568653], [8364, 100170477], [9031, 374075], [9544, 703000], [9598, 465759], [9606, 695], [9615, 119868479], [9913, 533459], [10090, 12229], [10116, 367901]], "id": 30953}, "interpro": [{"desc": "Pleckstrin homology domain", "id": "IPR001849", "short_desc": "PH_domain"}, {"desc": "PH-like domain superfamily", "id": "IPR011993", "short_desc": "PH-like_dom_sf"}, {"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "Serine-threonine/tyrosine-protein kinase, catalytic domain", "id": "IPR001245", "short_desc": "Ser-Thr/Tyr_kinase_cat_dom"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "SH2 domain superfamily", "id": "IPR036860", "short_desc": "SH2_dom_sf"}, {"desc": "SH2 domain", "id": "IPR000980", "short_desc": "SH2"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "Tyrosine-protein kinase, catalytic domain", "id": "IPR020635", "short_desc": "Tyr_kinase_cat_dom"}, {"desc": "SH3 domain", "id": "IPR001452", "short_desc": "SH3_domain"}, {"desc": "Zinc finger, Btk motif", "id": "IPR001562", "short_desc": "Znf_Btk_motif"}, {"desc": "Tyrosine-protein kinase, active site", "id": "IPR008266", "short_desc": "Tyr_kinase_AS"}, {"desc": "Tyrosine-protein kinase BTK, SH3 domain", "id": "IPR035574", "short_desc": "BTK_SH3"}, {"desc": "SH3-like domain superfamily", "id": "IPR036028", "short_desc": "SH3-like_dom_sf"}], "ipi": ["IPI00029132", "IPI00646149"], "map_location": "Xq22.1", "name": "Bruton tyrosine kinase", "other_names": ["B-cell progenitor kinase", "Bruton agammaglobulinemia tyrosine kinase", "Bruton's tyrosine kinase", "agammaglobulinaemia tyrosine kinase", "dominant-negative kinase-deficient Brutons tyrosine kinase", "tyrosine-protein kinase BTK"], "pantherdb": {"HGNC": "1133", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "88216", "ortholog_type": "LDO", "panther_family": "PTHR24418", "taxid": 10090, "uniprot_kb": "P35991"}, {"Ensembl": "ENSRNOG00000052407", "ortholog_type": "LDO", "panther_family": "PTHR24418", "taxid": 10116, "uniprot_kb": "A0A0G2K134"}, {"Ensembl": "ENSGALG00000004958", "ortholog_type": "LDO", "panther_family": "PTHR24418", "taxid": 9031, "uniprot_kb": "A0A1D5NXK5"}, {"Gene": "BTK", "ortholog_type": "LDO", "panther_family": "PTHR24418", "taxid": 9031, "uniprot_kb": "Q8JH64"}, {"Ensembl": "ENSDARG00000113249", "ortholog_type": "O", "panther_family": "PTHR24418", "taxid": 7955, "uniprot_kb": "A0A2R8RU01"}, {"ZFIN": "ZDB-GENE-070531-1", "ortholog_type": "LDO", "panther_family": "PTHR24418", "taxid": 7955, "uniprot_kb": "F8W3B7"}, {"FlyBase": "FBgn0003502", "ortholog_type": "O", "panther_family": "PTHR24418", "taxid": 7227, "uniprot_kb": "P08630"}], "uniprot_kb": "Q06187"}, "pathway": {"biocarta": [{"id": "bcrpathway", "name": "bcr signaling pathway"}, {"id": "fcer1pathway", "name": "fc epsilon receptor i signaling in mast cells"}, {"id": "ptdinspathway", "name": "phosphoinositides and their downstream targets"}], "kegg": [{"id": "hsa04064", "name": "NF-kappa B signaling pathway - Homo sapiens (human)"}, {"id": "hsa04380", "name": "Osteoclast differentiation - Homo sapiens (human)"}, {"id": "hsa04611", "name": "Platelet activation - Homo sapiens (human)"}, {"id": "hsa04662", "name": "B cell receptor signaling pathway - Homo sapiens (human)"}, {"id": "hsa04664", "name": "Fc epsilon RI signaling pathway - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05340", "name": "Primary immunodeficiency - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_BCR", "name": "BCR"}, {"id": "Pathway_IL6", "name": "IL6"}], "pid": [{"id": "bcr_5pathway", "name": "BCR signaling pathway"}, {"id": "epopathway", "name": "EPO signaling pathway"}, {"id": "faspathway", "name": "FAS (CD95) signaling pathway"}, {"id": "fcer1pathway", "name": "Fc-epsilon receptor I signaling in mast cells"}, {"id": "pi3kcipathway", "name": "Class I PI3K signaling events"}], "reactome": [{"id": "R-HSA-1236974", "name": "ER-Phagosome pathway"}, {"id": "R-HSA-1236975", "name": "Antigen processing-Cross presentation"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-1280218", "name": "Adaptive Immune System"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-166016", "name": "Toll Like Receptor 4 (TLR4) Cascade"}, {"id": "R-HSA-166058", "name": "MyD88:MAL(TIRAP) cascade initiated on plasma membrane"}, {"id": "R-HSA-168179", "name": "Toll Like Receptor TLR1:TLR2 Cascade"}, {"id": "R-HSA-168188", "name": "Toll Like Receptor TLR6:TLR2 Cascade"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168249", "name": "Innate Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168898", "name": "Toll-like Receptor Cascades"}, {"id": "R-HSA-181438", "name": "Toll Like Receptor 2 (TLR2) Cascade"}, {"id": "R-HSA-194315", "name": "Signaling by Rho GTPases"}, {"id": "R-HSA-195258", "name": "RHO GTPase Effectors"}, {"id": "R-HSA-2029480", "name": "Fcgamma receptor (FCGR) dependent phagocytosis"}, {"id": "R-HSA-2029482", "name": "Regulation of actin dynamics for phagocytic cup formation"}, {"id": "R-HSA-2172127", "name": "DAP12 interactions"}, {"id": "R-HSA-2424491", "name": "DAP12 signaling"}, {"id": "R-HSA-2454202", "name": "Fc epsilon receptor (FCERI) signaling"}, {"id": "R-HSA-2454202", "name": "Fc epsilon receptor (FCERI) signaling"}, {"id": "R-HSA-2871809", "name": "FCERI mediated Ca+2 mobilization"}, {"id": "R-HSA-2871809", "name": "FCERI mediated Ca+2 mobilization"}, {"id": "R-HSA-372790", "name": "Signaling by GPCR"}, {"id": "R-HSA-388396", "name": "GPCR downstream signalling"}, {"id": "R-HSA-397795", "name": "G-protein beta:gamma signalling"}, {"id": "R-HSA-416476", "name": "G alpha (q) signalling events"}, {"id": "R-HSA-416482", "name": "G alpha (12/13) signalling events"}, {"id": "R-HSA-5260271", "name": "Diseases of Immune System"}, {"id": "R-HSA-5602358", "name": "Diseases associated with the TLR signaling cascade"}, {"id": "R-HSA-5602498", "name": "MyD88 deficiency (TLR2/4)"}, {"id": "R-HSA-5603041", "name": "IRAK4 deficiency (TLR2/4)"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-5663213", "name": "RHO GTPases Activate WASPs and WAVEs"}, {"id": "R-HSA-8964315", "name": "G beta:gamma signalling through BTK"}, {"id": "R-HSA-9658195", "name": "Leishmania infection"}, {"id": "R-HSA-9664407", "name": "Parasite infection"}, {"id": "R-HSA-9664417", "name": "Leishmania phagocytosis"}, {"id": "R-HSA-9664422", "name": "FCGR3A-mediated phagocytosis"}, {"id": "R-HSA-9679191", "name": "Potential therapeutics for SARS"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9716542", "name": "Signaling by Rho GTPases, Miro GTPases and RHOBTB3"}, {"id": "R-HSA-9824443", "name": "Parasitic Infection Pathways"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}, {"id": "R-HSA-983169", "name": "Class I MHC mediated antigen processing & presentation"}, {"id": "R-HSA-983695", "name": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"}, {"id": "R-HSA-983695", "name": "Antigen activates B Cell Receptor (BCR) leading to generation of second messengers"}, {"id": "R-HSA-983705", "name": "Signaling by the B Cell Receptor (BCR)"}, {"id": "R-HSA-983705", "name": "Signaling by the B Cell Receptor (BCR)"}], "smpdb": {"id": "SMP00358", "name": "Fc Epsilon Receptor I Signaling in Mast Cells"}, "wikipathways": [{"id": "WP127", "name": "IL-5 signaling pathway"}, {"id": "WP1449", "name": "Regulation of toll-like receptor signaling pathway"}, {"id": "WP2203", "name": "Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway"}, {"id": "WP23", "name": "B Cell Receptor Signaling Pathway"}, {"id": "WP304", "name": "Kit receptor signaling pathway"}]}, "pdb": ["1AWW", "1AWX", "1B55", "1BTK", "1BWN", "1K2P", "1QLY", "2GE9", "2Z0P", "3GEN", "3K54", "3OCS", "3OCT", "3P08", "3PIX", "3PIY", "3PIZ", "3PJ1", "3PJ2", "3PJ3", "4NWM", "4OT5", "4OT6", "4OTF", "4OTQ", "4OTR", "4RFY", "4RFZ", "4RG0", "4RX5", "4YHF", "4Z3V", "4ZLY", "4ZLZ", "5BPY", "5BQ0", "5FBN", "5FBO", "5J87", "5JRS", "5KUP", "5P9F", "5P9G", "5P9H", "5P9I", "5P9J", "5P9K", "5P9L", "5P9M", "5T18", "5U9D", "5VFI", "5VGO", "5XYZ", "5ZZ4", "6AUA", "6AUB", "6BIK", "6BKE", "6BKH", "6BKW", "6BLN", "6DI0", "6DI1", "6DI3", "6DI5", "6DI9", "6E4F", "6EP9", "6HRP", "6HRT", "6HTF", "6J6M", "6N9P", "6NFH", "6NFI", "6NZM", "6O8I", "6OMU", "6S90", "6TFP", "6TSE", "6TT2", "6TUH", "6TVN", "6VXQ", "6W06", "6W07", "6W7O", "6W8I", "6X3N", "6X3O", "6X3P", "6XE4", "6YYF", "6YYG", "6YYK", "7KXL", "7KXM", "7KXN", "7KXO", "7KXP", "7KXQ", "7L5O", "7L5P", "7LTY", "7LTZ", "7N4Q", "7N4R", "7N4S", "7N5O", "7N5R", "7N5X", "7N5Y", "7R60", "7R61", "7YC9", "8DSO", "8E2M", "8EJB", "8FLG", "8FLH", "8FLL", "8FLN", "8FLV", "8GC7", "8GC8", "8U2D", "8U2E"], "pfam": ["PF00017", "PF07714", "PF00018", "PF00169", "PF00779"], "pharmgkb": "PA25454", "pharos": {"target_id": 8195, "tdl": "Tclin"}, "pir": "I37212", "prosite": ["PS50001", "PS50011", "PS50002", "PS50003", "PS51113"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF217568", "relationship": "is"}, {"id": "GNF246495", "relationship": "is"}, {"id": "GNF246496", "relationship": "is"}, {"id": "GNF246497", "relationship": "is"}, {"id": "GNF246498", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF035762", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF080195", "relationship": "is"}, {"id": "GNF080196", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF054998", "relationship": "is"}, {"id": "GNF059785", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065581", "relationship": "is"}, {"id": "GNF065582", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF165264", "relationship": "is"}, {"id": "GNF165265", "relationship": "is"}, {"id": "GNF165266", "relationship": "is"}, {"id": "GNF165267", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF275592", "relationship": "is"}, {"id": "GNF275593", "relationship": "is"}], "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324786", "relationship": "is"}, {"id": "GNF324787", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF336515", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF092876", "relationship": "is"}, {"id": "GNF132574", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000023.11", "NC_060947.1", "NG_009616.1"], "protein": ["NP_000052.1", "NP_001274273.1", "NP_001274274.1"], "rna": ["NM_000061.3", "NM_001287344.2", "NM_001287345.2"], "translation": [{"protein": "NP_001274273.1", "rna": "NM_001287344.2"}, {"protein": "NP_001274274.1", "rna": "NM_001287345.2"}, {"protein": "NP_000052.1", "rna": "NM_000061.3"}]}, "reporter": {"HG-U133_Plus_2": "205504_at", "HG-U95Av2": "38213_at", "HTA-2_0": ["TC0X001218.hg.1", "TC0X002155.hg.1"], "HuEx-1_0": "4015709", "HuGene-1_1": "8174051", "HuGene-2_1": "17112735"}, "summary": "The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013].", "symbol": "BTK", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1412841"}, "unigene": ["Hs.733206", "Hs.159494"], "uniprot": {"Swiss-Prot": "Q06187", "TrEMBL": ["Q3MS90", "Q5JY90", "Q3MS97", "Q3MS94", "A0A8Q3WLR2", "Q3MS88", "A0A8Q3SI44", "A0A8Q3SHX9", "A0A8Q3WKR7", "A0A8Q3SI38", "A0A8Q3WKS7", "A0A8Q3WKN1", "A0A8Q3WL62", "A0A8Q3SHZ6", "A0A8Q3SI35", "A0A8Q3WLZ5", "A0A8Q3WKM0"]}, "wikipedia": {"url_stub": "Bruton's tyrosine kinase"}}